Bioscience

🔒 Expanding New Haven biotech Revalia Bio uses donated human organs to test drugs

Revalia Bio plans to expand its New Haven workforce as pharma demand grows for human-organ testing and its technology advances.

Plans for Unilever’s New Haven innovation center detail $34.7M in state infrastructure support

Winstanley Enterprises is the developer behind the project, which would expand New Haven's life sciences district.

Decision 2026: Lamont touts fiscal record in bid for third term as affordability concerns persist

Ned Lamont says stronger state finances give Connecticut more room to invest in education, health care and infrastructure.

Yale bioscience spinout Revalia Bio names Eli Lilly exec CEO

Yale spinout Revalia Bio names Casimir Starsiak III CEO as co-founder Greg Tietjen moves to chief innovation officer.
ADVERTISEMENT

New Haven biotech raises $33M for cancer drug development

Cloverleaf Bio will use the funding to move its RNA-based liver cancer treatment into early-stage human testing.

🔒 New Haven biotech seeks to raise $150M for drug development

Yarrow Bioscience said it will use the funds for research and development as it seeks treatments for autoimmune thyroid diseases.

CT drugmaker partners on development of inhaled weight-loss treatment

The partnership involving Danbury-based MannKind Corp. will test whether a fast-acting inhaled GLP-1 drug could offer patients more flexibility than existing treatments.

Hartford HealthCare, Yale NH Health mark opening of $75M proton therapy center

The $75 million Wallingford center brings proton therapy to Connecticut, eliminating the need for patients to travel out of state.
ADVERTISEMENT

New Haven COVID drugmaker names new CEO ahead of key trial results

Invivyd is entering a critical stretch as rising losses and a looming regulatory deadline put added weight on its next drug candidate.

🔒 New Haven biotech BioXcel files for bankruptcy, agrees to potential $145M sale

BioXcel's bankruptcy and potential sale come as the New Haven biotech seeks a path forward after years of losses.
ADVERTISEMENT

Latest Stories

More Business News

Thought Leadership

More Thought Leadership
ADVERTISEMENT

Movers & Shakers

More Movers & Shakers | Submit Movers & Shakers

Business Announcements

More Announcements | Submit Business Announcements

Upcoming Events

More Events | Submit an Event